Listen Live
Donate
 on air
    Schedule

    KCRW

    Read & Explore

    • News
    • Entertainment
    • Food
    • Culture
    • Events

    Listen

    • Live Radio
    • Music
    • Podcasts
    • Full Schedule

    Information

    • About
    • Careers
    • Help / FAQ
    • Newsletters
    • Contact

    Support

    • Become a Member
    • Become a VIP
    • Ways to Give
    • Shop
    • Member Perks

    Become a Member

    Donate to KCRW to support this cultural hub for music discovery, in-depth journalism, community storytelling, and free events. You'll become a KCRW Member and get a year of exclusive benefits.

    DonateGive Monthly

    Copyright 2026 KCRW. All rights reserved.

    Report a Bug|Privacy Policy|Terms of Service|
    Cookie Policy
    |FCC Public Files|

    Back to Press Play with Madeleine Brand

    Press Play with Madeleine Brand

    The promise of immunotherapy

    Six years ago, the writer Mary Elizabeth Williams got a terrifying diagnosis. She had melanoma, a deadly skin cancer. It eventually spread to stage 4, and the prognosis was terminal. As a last-ditch effort, Williams joined a clinical trial for a still-novel treatment called immunotherapy .

    • rss
    • apple-podcasts
    • spotify
    • Share
    By Madeleine Brand • Aug 8, 2016 • 1 min read

    Six years ago, the writer Mary Elizabeth Williams got a terrifying diagnosis. She had melanoma, a deadly skin cancer. It eventually spread to stage 4, and the prognosis was terminal. As a last-ditch effort, Williams joined a clinical trial for a still-novel treatment called immunotherapy. And today she is not only alive, but she’s been in complete remission for almost five years. For Williams, immunotherapy has been nothing short of miraculous, but she’s the exception. Most cancers, so far, don’t respond to these new experimental treatments.

    Link to Mary Elizabeth’s book

    The full episode

    4 of 5
    How hard have trade agreements hit Motor City?
    1. 0:30How hard have trade agreements hit Motor City?
    2. 10:17Could hackers disrupt election day?
    3. 19:13Touring the Hermitage Museum with Art Talk's Edward Goldman
    4. 28:18The promise of immunotherapyYou’re reading this
    5. 42:44The lowdown on Netflix's 'The Get Down'
    • https://images.ctfassets.net/2658fe8gbo8o/AvYox6VuEgcxpd20Xo9d3/769bca4fbf97bf022190f4813812c1e2/new-default.jpg?h=250

      Madeleine Brand

      Host, 'Press Play'

    • KCRW placeholder

      Barbara Bogaev

      radio journalist

    • https://images.ctfassets.net/2658fe8gbo8o/AvYox6VuEgcxpd20Xo9d3/769bca4fbf97bf022190f4813812c1e2/new-default.jpg?h=250

      Matt Holzman

      Producer, 'The Document'

    • https://images.ctfassets.net/2658fe8gbo8o/AvYox6VuEgcxpd20Xo9d3/769bca4fbf97bf022190f4813812c1e2/new-default.jpg?h=250

      Anna Scott

      Former KCRW Housing and Homelessness Reporter

    • KCRW placeholder

      Jolie Myers

      Managing Producer, 'Press Play'

    • KCRW placeholder

      Mary Elizabeth Williams

      Salon

    • KCRW placeholder

      Jedd Wolchok

      Memorial Sloan Kettering Cancer Center

      News

    The full episode

    4 of 5
    How hard have trade agreements hit Motor City?
    1. 0:30How hard have trade agreements hit Motor City?
    2. 10:17Could hackers disrupt election day?
    3. 19:13Touring the Hermitage Museum with Art Talk's Edward Goldman
    4. 28:18The promise of immunotherapyYou’re reading this
    5. 42:44The lowdown on Netflix's 'The Get Down'
    Back to Press Play with Madeleine Brand